LexaGene Holdings Inc.
Limited financial coverage for LXXGF.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
About the company
LexaGene Holdings Inc. is a biotechnology firm dedicated to the innovation, development, and market release of systems designed for identifying pathogens. Its core offering is MiQLab, an automated pathogen detection platform poised to revolutionize how pathogens are detected in diverse fields, including veterinary and human clinical diagnostics, food and water safety analysis, and other life science applications.
- CEO
- John F. Regan
- Employees
- 33
- HQ
- Beverly, MA, US
Price Chart
- Revenue
- $75.31K · 29.57%
- Net Income
- $-10,620,000 · -6.56%
- EPS
- $-0.09 · 6.44%
- Op Income
- $-10,638,000
- FCF YoY
- -6.05%
- 52W High
- $0.22
- 52W Low
- $0.05
- 50D MA
- $0.15
- 200D MA
- $0.13
- Beta
- 2.04
- Avg Volume
- 223.59K
Get TickerSpark's AI analysis on LXXGF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our LXXGF coverage
Recent articles, reports, and earnings notes.
No research on LXXGF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate LXXGF report →Similar companies
Peers in the same neighborhood.